Kidney cancer

PBRM1 loss promotes tumour response to immunotherapy

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1

    Miao, D. et al. Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma. Science https://doi.org/10.1126/science.aan5951 (2018)

    CAS  Article  Google Scholar 

Download references

Authors

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Otto, G. PBRM1 loss promotes tumour response to immunotherapy. Nat Rev Clin Oncol 15, 134–135 (2018). https://doi.org/10.1038/nrclinonc.2018.12

Download citation

Further reading